BMS Archive

Plant · Scientific monograph

Cynara cardunculus

Artichoke

For educational and scientific research only. Not medical advice. Independently verify claims against the cited primary sources. Consult a qualified healthcare professional before using any plant or fungal preparation.

Research areas: Digestive health, Lipid metabolism

Research overview

Historical use

Artichoke leaf has documented traditional use for fullness, bloating and flatulence; EMA categorizes this digestive indication as traditional use [4].

Modern research context

Artichoke leaf extracts have been investigated for functional dyspepsia and lipid biomarkers [1][2][3]. In a 6-week RCT (247 enrolled), a commercial leaf extract improved symptom scores versus placebo [1]. Meta-analyses reported lipid changes across varying products; cardiovascular event prevention is unproven [2][3]. BMS Level B provisional for the specific dyspepsia preparation and lipid markers, with full-text bias review pending; EMA traditional-use status remains distinct [4].

Adverse effects

Mild diarrhea, abdominal spasm, nausea, heartburn and allergic reactions are reported; frequencies are unknown [4].

Contraindications

EMA lists Asteraceae hypersensitivity, bile-duct obstruction, cholangitis, liver disease, gallstones and other biliary disorders requiring medical advice. Use below age 12 is not established [4]. Persistent digestive symptoms beyond two weeks warrant medical advice [4].

Clinical and phytochemical data

Used part

Leaf extract of cultivated artichoke, reported in literature as Cynara scolymus; evidence must not be transferred to all C. cardunculus varieties or edible hearts. EMA covers specified leaf preparations [1][4].

Primary active compounds

  • Commercial leaf-extract mixture; the retrieved trial abstract does not identify constituent concentrations or clinical standardization, so no individual active compound is assigned [1].

Mechanism of action

Digestive symptom modulation and lipid metabolism are studied outcomes; molecular causation is not established by the retrieved human trials. No specific molecular target is assigned here [1][2][3].

Pharmacokinetics

Absorption

Human absorption of the trial extract is not characterized in the retrieved studies; no bioavailability estimate assigned [1][4].

Distribution

Human tissue distribution is not characterized in the retrieved sources [1][4].

Metabolism

Human metabolism of the whole leaf extract is not characterized in this extraction; no CYP claim assigned [4].

Excretion

No human elimination route or half-life established for the whole extract in the retrieved sources [4].

Safety and interactions

Drug interactions

EMA reports no interactions; formal interaction data remain limited. This does not establish compatibility with all medicines [4].

Toxicity

Long-term human toxicity is not established by short trials. EMA notes inadequate reproductive, genotoxicity and carcinogenicity testing; no quantified human safe maximum is assigned [1][4].

Special precautions

Pregnancy

Safety unestablished; EMA does not recommend medicinal use during pregnancy [4].

Lactation

Safety unestablished; EMA does not recommend medicinal use during lactation [4].

Hepatic impairment

Liver disease and biliary disease are listed contraindications in EMA; experimental liver research does not override this [4].

Renal impairment

No renal dose-adjustment evidence identified; renal-impairment safety remains insufficiently characterized [4].

Sources and references

  1. [1] - Holtmann G, Adam B, Haag S, Collet W, Grünewald E, Windeck T. Efficacy of artichoke leaf extract in the treatment of patients with functional dyspepsia: a six-week placebo-controlled, double-blind, multicentre trial. Alimentary pharmacology & therapeutics 2003. PMID: 14653829. DOI: 10.1046/j.1365-2036.2003.01767.x.
  2. [2] - Sahebkar A, Pirro M, Banach M, Mikhailidis DP, Atkin SL, Cicero AFG. Lipid-lowering activity of artichoke extracts: A systematic review and meta-analysis. Critical reviews in food science and nutrition 2018. PMID: 28609140. DOI: 10.1080/10408398.2017.1332572.
  3. [3] - Shahinfar H, Bazshahi E, Amini MR, Payandeh N, Pourreza S, Noruzi Z, Shab-Bidar S. Effects of artichoke leaf extract supplementation or artichoke juice consumption on lipid profile: A systematic review and dose-response meta-analysis of randomized controlled trials. Phytotherapy research : PTR 2021. PMID: 34569671. DOI: 10.1002/ptr.7247.
  4. [4] - EMA/HMPC. Official herbal monograph, full regulatory text, sections 4.3–5.3. https://www.ema.europa.eu/en/documents/herbal-monograph/final-european-union-herbal-monograph-cynara-cardunculus-l-syn-cynara-scolymus-l-folium_en.pdf Accessed 2026-10-25.

Additional source links

Continue browsing